BIOMERICA INC
10.03%
460,080
73290
Aug 24, 2026
Aug 28, 2026, 05:20 PM
Reporting Persons (3)
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| BRC Group Holdings, Inc. | Holding Company | 10.03% | 460,080 | 0 | 460,080 |
| B. Riley Principal Capital, LLC | Other | 10.03% | 460,080 | 0 | 460,080 |
| Bryant R. Riley | Individual | 10.03% | 460,080 | 0 | 460,080 |
Disclosure Items (7)
Common Stock, par value $0.08 per share
BIOMERICA INC
17571 Von Karman Avenue, Irvine, CA, 92614
(a) This Schedule 13D is being filed by the following persons (each, a "Reporting Person" and collectively, the "Reporting Persons"): (1) BRC Group Holdings, Inc., a Delaware corporation ("BRC"); (2) B. Riley Principal Capital, LLC, a Delaware limited liability company ("BRPC"); and (3) Bryant R. Riley, an individual ("Riley").
11100 Santa Monica Blvd. Suite 800, Los Angeles, CA 90025.
The principal business of BRC is serving as a holding company. The principal business of BRPC is making investments. Riley is the Co-Chief Executive Officer and Chairman of the Board of Directors of BRC.
During the last five years, none of the Reporting Persons nor any person listed on Schedule A have been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
BRC is a Delaware corporation. BRPC is a Delaware limited liability company. Riley is a citizen of the United States of America.
The aggregate purchase price of the 460,080 shares of Common Stock was $736,128 (the "Purchased Shares"). The source of funds for acquiring the Purchased Shares that are directly owned by BRPC was working capital of BRPC.
(1) As of the date hereof, BRC may be deemed to indirectly beneficially own 480,060 shares of Common Stock held by BRC, representing 10.03% of the Issuer's Common Stock. BRPC is a subsidiary of BRC. (2) BRPC beneficially owns directly 480,060 shares of Common Stock, representing 10.03% of the Issuer's Common Stock. (3) Bryant Riley may be deemed to indirectly beneficially own 480,060 shares of Common Stock, representing 10.03% of the Issuer's Common Stock outstanding and held directly by BRPC in the manner specified in paragraph (2) above. Bryant R. Riley disclaims beneficial ownership of the shares held by BRPC except to the extent of his pecuniary interest therein.
The Reporting Persons directly own, has the shared power to vote or direct the vote of, and the shared power to dispose or direct the disposition of 480,060 shares of Common Stock of the Issuer. Based upon a total of 4,588,968 outstanding shares of Common Stock as of August 20, 2026, the Reporting Persons shares represent approximately 10.03% of the outstanding shares of Common Stock.
Except for the transactions described in Item 4 herein, the Reporting Persons have not engaged in any transaction during the past 60 days involving the common stock of the Issuer.
Not applicable.
Not applicable.
The Reporting Persons' response to Item 4 is incorporated by reference into this Item 6. The description of the securities purchase agreement is qualified in its entirety by reference to the full text of the securities purchase agreement, which is filed as Exhibit 2 and incorporated herein by reference. The description of the registration rights agreement is qualified in its entirety by reference to the full text of the registration rights agreement, which is filed as Exhibit 2 and incorporated herein by reference.
Exhibit No. Description Schedule A Executive Officers and Directors of BRC Group Holdings, Inc. 1* Joint Filing Agreement by and among the Reporting Persons. 2 Securities Purchase Agreement, dated August 20, 2026, by and among Bioamerica, Inc and certain Purchasers (incorporated by reference to Exhibit 10.1 to the Issuer's Current Report on Form 8-K filed with the SEC on August 26, 2026). 3 Registration Rights Agreement, dated August 20, 2026, by and among Bioamerica, Inc. and certain Purchasers (incorporated by reference to Exhibit 10.2 to the Issuer's Current Report on Form 8-K filed with the SEC on August 26, 2026). * Filed herewith.